RxDoctor Payments Data

Laurie Glimcher

Rheumatology · New York, NYNPI 1952351488

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,871,279 of the $3,871,502 with a category attached, or 100.0%. 4 manufacturers reported payments, led by Bristol Myers Squibb at 56.7% of the total. Reporting peaked in 2019 at $1,176,597 and has fallen 100.0% since, to $93 in 2024. Among rheumatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,871,502in general payments, 2019–2025

Across 23 payments — averaging $168,326 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$2.2M
  • GSK$887K
  • E.r. Squibb & Sons, L.L.C.$791K
  • Vertex$93

What the payments were for

  • Speaking & faculty fees$3,871,279100%
  • Food & beverage$1300%
  • Gifts$930%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb12$2,193,860
GSK5$887,018
E.r. Squibb & Sons, L.L.C.4$790,532
Vertex2$93

How this compares

$3,871,502 in reported general payments places this provider in the 95th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Other rheumatology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →